Fig.2From: Low-dose intravenous plus inhaled versus intravenous polymyxin B for the treatment of extensive drug-resistant Gram-negative ventilator-associated pneumonia in the critical illnesses: a multi-center matched case–control studyComparison of clinical cure and improvement in the different subgroups. SOFA, Sequential Organ Failure Assessment; XDR, extensively drug-resistant; A. baumannii, Acinetobacter baumannii; E. coli, Escherichia coli; K. pneumoniae, Klebsiella pneumoniae; P. aeruginosa, Pseudomonas aeruginosaBack to article page